Avadel Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) has announced that its management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 15, 2023, at 1:00 p.m. ET. A live webcast and archived recording of the chat will be accessible on Avadel’s Investor Relations website for 90 days post-conference. Avadel is focused on innovative biopharmaceutical solutions, particularly an investigational sodium oxybate formulation aimed at treating cataplexy and excessive daytime sleepiness in adults with narcolepsy. For further details, visit www.avadel.com.

DUBLIN, Ireland, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15 at 1:00 p.m. ET.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Gabriella Greig
Real Chemistry
ggreig@realchemistry.com
(203) 249-2688

FAQ

What date is the Avadel Pharmaceuticals AVDL fireside chat scheduled for?

The Avadel Pharmaceuticals fireside chat is scheduled for February 15, 2023.

What time will Avadel Pharmaceuticals participate in the fireside chat?

Avadel Pharmaceuticals will participate in the fireside chat at 1:00 p.m. ET.

Where can I find the webcast for the Avadel Pharmaceuticals events?

The webcast for the Avadel Pharmaceuticals events can be found on their Investor Relations website.

How long will the archived recording of the Avadel Pharmaceuticals fireside chat be available?

The archived recording of the fireside chat will be available for 90 days after the event.

What is the focus of Avadel Pharmaceuticals' current lead drug candidate?

Avadel Pharmaceuticals' current lead drug candidate focuses on treating cataplexy and excessive daytime sleepiness in adults with narcolepsy.